The efficiency of endothelin receptor antagonist bosentan for pulmonary arterial hypertension associated with congenital heart disease: A systematic review and meta-analysis.

Background: Oral bosentan has been widely applied in pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD). A systemic review and meta-analysis was conducted for a therapeutic evaluation of oral bosentan in both adult and pediatric patients with PAH-CHD. The acute respon...

Full description

Bibliographic Details

Published in:	Medicine Vol. 97; no. 10; pp. 1 - 10
Main Authors:	Hong-Yu Kuang, Yu-Hao Wu, Qi-Jian Yi, Jie Tian, Chun Wu, We Nian Shou, Tie-Wei Lu, Kuang, Hong-Yu, Wu, Yu-Hao, Yi, Qi-Jian, Tian, Jie, Wu, Chun, Shou, We Nian, Lu, Tie-Wei
Format:	Journal Article
Published:	Lippincott Williams & Wilkins Mar2018
Online Access:	View this record in EBSCOhost